We lead work to develop and evaluate new models of care and interventions to address the key challenges associated with long-term conditions in today's health service.
This includes research related to Stroke, lower back pain, COPD, Rheumatoid arthritis, Falls prevention, Dementia, Smoking cessation and Diabetes
- Professor Paramjit Gill is currently involved in research as follows:
STREAM - Screen and Treat For Malnutrition - NIHR funded project to develop and test a mixed digital and non-digital behaviour change intervention for older people, to be delivered in primary care. To identify people who may be at risk of malnutrition, and offer treatment with dietary advice, oral nutritional supplements or referral to a dietitian, depending on people’s needs.
PPP-GDM - Pakistan Prevention Programme for Gestational Diabetes Mellitus, funded by MRC.
Cerebral Vasomotor Regulation in Atrial Fibrillation Study - funded by British Heart Foundation.
CAADDI - Carbohydrate Awareness Advice by Dietitians in Diabetes - NIHR Doctoral Training Fellowship.
IMPRESS-AF - IMproved exercise tolerance in patients with PReserved Ejection fraction by Spironolactone on myocardial fibrosiS in Atrial Fibrillation.
- Professor David Fitzmaurice is currently involved in research as follows:
COPD in Primary Care: from case finding to improving patient outcomes - NIHR Programme Grant (ends March 2018)
Improving the prevention and treatment of Venous Thromboembolism in Hospital and the Community - NIHR Programme Grant (ends January 2018)
Prospective, multicentre, international Registry of male and female patients newly diagnosed with atrial fibrillation (GARFIELD) - Funded by Thrombosis Research Institute (ends January 4th 2019)
Cognitive behavioural therapy to reduce anxiety and depression in patients with atrial fibrillation (CBT-AF): Randomised controlled trial to determine if cognitive behavioural therapy can reduce anxiety and depression in atrial fibrillation patients compared to usual care. - funded by National Institute for Health Research (NIHR), Research for Patient Benefit (RfPB) (ends April 2019)